N/A N=494 PictureRx: Improving Medication Safety in Health Disparity Populations
Medication Reconciliation
Primary: Number of Participants With Changes/Updates in Medication List — 101; 43 Participants — p=<0.0001
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=402 Regional Data Exchange to Improve Medication Safety
Drug Toxicity
Primary: Transition Drug Risk — 6.4; 5.8 units: risk-weighted discrepancies — p=0.175
N/A N=156 Eliminating Risk of Preventable Adverse Drug Events at the Hospital-community Interface of Care
Adverse Drug Events
Primary: Health Services Utilization 3 Months Following Hospital Discharge — 3.33; 3.40 Health Services Utilizations — p=.87
N/A N=240 The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial
Drug-Related Side Effects and Adverse Reactions · Adverse Drug Events
Primary: Medication Discrepancies — 6.4; 4.4 Medication Discrepancies
N/A N=301 Development and Evaluation of an Electronic Health Record-based Medication Complete Communication (EMC2) Strategy
Medication Adherence
Primary: Medication Specific Knowledge — 63.82; 62.80 score (0-100)
N/A N=920 Northwestern University and Access Community Health Network Medication Education Study
Hypertension
Primary: Systolic Blood Pressure — 134.5; 141.7; 134.6 mm Hg
N/A N=306 Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy
Adverse Drug Events
Primary: Mean Severity-weighted Admission Medication History (AMH) Error Score — 23; 4.1; 4.1 Mean Severity-weighted AMH Error Score
N/A N=52 The Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications to Improve Patient Safety and Care
Diabetes Mellitus, Type 2 · Hypertension · Hyperlipidemia
Primary: Primary Effectiveness Outcome - LDL — 57.9; 54.8 percentage of time spent at goal
N/A N=66 Mobile Application to Enhance Medication Management
Medication Adherence · Mobile Application
Primary: Usability of the SAM App — 1.14; 1.32; 1.35; 1.81 score on a scale
N/A N=5,421 Medication Adherence Clinical Decision Support
Hyperlipidemia · Hypertension · Diabetes
Primary: Blood Pressure Medication Adherence — 396; 470 Participants — p=0.0103
N/A N=198 Discharge Medication Counseling in Hospitalized Children
Medication Management
Primary: Observed Dosing Accuracy — 3.3; 1.0 percent difference — p=<0.001
N/A N=19 The Adverse Drug Reaction (ADRe) Profile for Polypharmacy
Polypharmacy
Primary: Number of Participants With Changes in Signs and Symptoms Related to Adverse Effects of Prescribed Medicines. Clinical Gains and Benefits to Residents — 17 Participants
N/A N=677 A Universal Medication Schedule to Promote Adherence to Complex Drug Regimens
Adherence
Primary: Medication Adherence - Pill Count — 0.46; 0.53 Probability of adherence (PT/PP => 0.8) — p=0.04
N/A N=652 EHR-Based Medication Complete Communication Strategy to Promote Safe Opioid Use
Opioid Use, Unspecified
Primary: Safe Medication Dosing (Prescription Understanding) — 0.67; 0.83; 0.79 probability
N/A N=40 Assessing the Effectiveness and Safety of the ID-Cap System for Medication Monitoring and Adherence
Medication Adherence
Primary: Medication Adherence — 94.8; 82.8 percentage of doses taken
N/A N=843 Personalized Health Assessment Related to Medications (Project PHARM)
Feedback, Psychological · Clinical Trial · Substance Abuse
Primary: Change in Past 6 Month Non-Medical Use of Prescription Stimulant Medication Frequency — -2.04; -1.72; -1.03; -.38 Usage days — p=0.03
N/A N=135 Reducing Disparities in Medication Adherence in SLE
Systemic Lupus Erythematosus
Primary: Feasibility as Measured by Number of Participants With EMR (Electronic Medical Record) Documentation of Adherence — 116 Participants
N/A N=452 Promoting the Universal Medication Schedule Via Mobile and EHR Technologies
Type 2 Diabetes
Primary: Prescription Understanding — 0.81; 0.82; 0.78 Probability
N/A N=58 VA Integrated Medication Manager
Electronic Health Records
Primary: Amount of Time to Complete Assessment and Plan — 8.5; 8.7 minutes — p=0.047
N/A N=862 Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)
Acute Coronary Syndrome · Heart Failure
Primary: Number of Serious Medication Errors as Determined by Interview and Medical Chart Review — 0.95; 0.87 serious medication errors
N/A N=1,005 Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial
High-risk Medications
Primary: Medication Knowledge (0-100) — 71.2; 71.9; 73.2; 74.9 score on a scale
N/A N=22 Shared Decision Making About Medication Use for People With Multiple Health Problems
Polypharmacy · Dementia · Multiple Chronic Conditions
Primary: Preliminary Efficacy of the Intervention to be Assessed From Primary Care Clinician's Intervention Visit Clinical Notes and EHR — 15; 7; 7; 7 Participants
N/A N=40 Heart Failure Medication Adherence
Heart Failure
Primary: Adherence to Medication — 2; 3 Participants
N/A N=23 Standardized Patient-Centered Medication Review in Home Hospice
Hospices · Poly Pharmacy · Deprescriptions
Primary: Intervention Training Completion by Hospice Staff — 17; 0 Participants
N/A N=60 Smart Capsule for Automatic Adherence Monitoring
Medication Adherence
Primary: Medication Adherence — 88.1; 96.6; 94.4 percentage of doses taken (pill count)
N/A N=119 Development & Pilot of the Technology-Enabled Alliance for Medication Therapy Management
Polypharmacy
Primary: Medication Reconciliation — 0.14; 0.17 number of discrepancies per medication
N/A N=75 Patient-Centered Medication Adherence Intervention for Schizophrenia
Schizophrenia
Primary: Antipsychotic Medication Adherence — 63.9; 75.0 percentage of participants — p=0.03
N/A N=23 Medication Adherence With Polyglot Meducation
Hypertension · Diabetes · Hypercholesterolemia
Primary: Medication Possession Ratio at Baseline — 65.0 percentage of medication possession
N/A N=1,499 The Pharmacist Follows You and Your Medication From Hospital to Your Daily Life and Investigate What This Means to You
Cross-Sectional Study
Primary: Readmissions — 111; 98; 68 Participants
N/A N=149 Medication Education for Dosing Safety
Pain · Fever
Primary: Number of Participants Reporting Safe Dosing at 48-72 Hours — 28; 25 Participants